DiabetesSeriesLive

CME Speakers

Treatment of Type 2 Diabetes: A Comprehensive Approach

  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician; Medical Director of Continuing Medical Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Martin J. Abrahamson, MD

    Martin J. Abrahamson, MD

    Martin J. Abrahamson, MD

    Associate Professor of Medicine

    Dr. Abrahamson is Associate Professor of Medicine at Harvard Medical School and Medical Director at the Joslin Diabetes Center in Boston, Massachusetts. He co-directs the Joslin – Beth Israel Deaconess Medical Center (BIDMC) Diabetes-Heart Program, a joint venture between Joslin Clinic and the Division of Cardiology at BIDMC. At Beth Israel Deaconess Medical Center, Dr. Abrahamson also serves as Director of the Division of Continuing Medical Education in the Department of Medicine. At Joslin Clinic, Dr. Abrahamson is credited with reorganizing the Adult Diabetes Section into multidisciplinary teams comprised of physicians, nurse practitioners, nurse educators, nutritionists, and exercise physiologists. He is spearheading “pathways of care” for patients referred to Joslin (JoslinCare), has co-authored guidelines for both the pharmacological and perioperative management of patients with diabetes and management of hyperglycemic emergencies, and has authored more than 50 papers, review articles and chapters related to diabetes. He received his medical degree from University of Cape Town in Cape Town, South Africa, and completed his internship and residency in internal medicine and endocrinology at Groote Schuur Hospital, also in Cape Town, where he was a research fellow before joining the faculty of medicine at the University of Cape Town and Groote Schuur Hospital. Dr. Abrahamson was joint head of the endocrine unit in Cape Town before taking up a faculty appointment at Harvard Medical School and Beth Israel Hospital in 1992. Dr. Abrahamson’s research interests include evaluation of the efficacy and utility of a continuous glucose monitoring sensors in the management of patients with diabetes, and prevalence of silent coronary ischemia in patients with diabetes. Dr. Abrahamson is board certified in internal medicine and in endocrinology, diabetes and metabolism, and is a Fellow of the College of Physicians of South Africa.
  • Vivian A. Fonseca, MD, FRCP

    Vivian A. Fonseca, MD, FRCP

    Vivian A. Fonseca, MD, FRCP

    Professor of Medicine and Pharmacology; Chief, Section of Endocrinology

    Vivian A. Fonseca, MD, FRCP, is a professor of medicine and pharmacology, the Tullis-Tulane Alumni Chair in Diabetes, and chief, Section of Endocrinology, at Tulane University Health Sciences Center in New Orleans, Louisiana. His current research interests include the prevention and treatment of diabetic complications and risk factor reduction in cardiovascular disease. Dr Fonseca is a fellow of the American Association of Clinical Endocrinologists, the Royal College of Physicians (London) and the American College of Physicians, and is a member of the Endocrine Society, the American Diabetes Association, and the International Diabetes Federation. He serves on numerous national and international committees, and has published more than 200 papers, review articles and book chapters.

Evolution of Insulin Replacement Therapy

  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician; Medical Director of Continuing Medical Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Richard Pratley, MD

    Richard Pratley, MD

    Richard Pratley, MD

    Samuel E. Crockett Chair in Diabetes Research; Director

    Richard E. Pratley, MD, is medical director of education and research at the Florida Hospital Diabetes Institute, senior investigator and diabetes program lead at the Translational Research Institute for Metabolism and Diabetes, and adjunct professor at the Sanford-Burnham Prebys Medical Discovery Institute in Orlando. His research interests include diabetes prevention, improving the care for older persons with diabetes, new drug development to treat and prevent diabetes and its complications, and understanding the role of the fat cell in increasing the risk of diabetes and heart disease. He is a member of numerous professional organizations, and is as an editorial board member and/or ad hoc reviewer for various journals. He received his MD from Wayne State University in Detroit, Michigan.
  • Anne L. Peters, MD

    Anne L. Peters, MD

    Anne L. Peters, MD

    Director, Clinical Diabetes Program; Professor, Keck School of Medicine

    Anne L. Peters, MD, is a professor of clinical medicine at the Keck School of Medicine of the University of Southern California in Los Angeles and the director of the USC Clinical Diabetes Program. Her interests involve translating research findings, from lifestyle interventions to technology, to people with diabetes throughout the socioeconomic spectrum. She is currently the chair of the Endocrine Society Committee on Diabetes Devices and is on the EASD/ADA Technology Safety Committee. Dr Peters has published over 200 articles, reviews and abstracts, and 3 books on diabetes, and has been an investigator on over 40 research studies. She earned her medical degree from the Pritzker School of Medicine at the University of Chicago in Illinois.
  • Jeremy H. Pettus, MD

    Jeremy H. Pettus, MD

    Jeremy H. Pettus, MD

    Assistant Professor of Medicine, Division of Endocrinology

    Jeremy H. Pettus, MD, is an assistant professor of medicine in the Division of Endocrinology at the University of California, San Diego (UCSD). After being diagnosed with type 1 diabetes himself at the age of 15, Dr Pettus has dedicated his career toward treating and educating others with the disease. He now specializes in type 1 diabetes-related clinical research with studies involving immunotherapeutics, islet cell encapsulation, and adjunctive therapies beyond insulin. He also has a background in basic immunology research with a focus on biomarkers for type 1 diabetes disease activity. In addition to his clinical duties, he is a speaker for the not-for-profit organization, Taking Control of Your Diabetes (TCOYD). He earned his medical degree from Boston University School of Medicine.

Diabetic Retinopathy

Concentrated Insulins

  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Wendy S. Lane, MD

    Wendy S. Lane, MD

    Wendy S. Lane, MD

    Director of Clinical Research

    Wendy S. Lane, MD, is a clinical endocrinologist and director of clinical research at the Mountain Diabetes and Endocrine Center in Asheville, North Carolina. Dr Lane has served as principal investigator or sub-investigator for multiple clinical trials for new and investigational oral and injectable medications and insulins for the treatment of type 1 and type 2 diabetes, as well as glucose sensor and insulin pump trials. She has been an author and investigator for several investigator-initiated trials of U-500 insulin via insulin pump and trials involving combinations of GLP-1 receptor agonist therapy with insulin. She was also a contributing author to 2014 AACE Guidelines on Insulin Pump Therapy. Dr Lane earned her medical degree at Dartmouth Medical School in Hanover, New Hampshire.
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician; Medical Director of Continuing Medical Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.

All Speakers

  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician; Medical Director of Continuing Medical Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Martin J. Abrahamson, MD

    Martin J. Abrahamson, MD

    Martin J. Abrahamson, MD

    Associate Professor of Medicine

    Dr. Abrahamson is Associate Professor of Medicine at Harvard Medical School and Medical Director at the Joslin Diabetes Center in Boston, Massachusetts. He co-directs the Joslin – Beth Israel Deaconess Medical Center (BIDMC) Diabetes-Heart Program, a joint venture between Joslin Clinic and the Division of Cardiology at BIDMC. At Beth Israel Deaconess Medical Center, Dr. Abrahamson also serves as Director of the Division of Continuing Medical Education in the Department of Medicine. At Joslin Clinic, Dr. Abrahamson is credited with reorganizing the Adult Diabetes Section into multidisciplinary teams comprised of physicians, nurse practitioners, nurse educators, nutritionists, and exercise physiologists. He is spearheading “pathways of care” for patients referred to Joslin (JoslinCare), has co-authored guidelines for both the pharmacological and perioperative management of patients with diabetes and management of hyperglycemic emergencies, and has authored more than 50 papers, review articles and chapters related to diabetes. He received his medical degree from University of Cape Town in Cape Town, South Africa, and completed his internship and residency in internal medicine and endocrinology at Groote Schuur Hospital, also in Cape Town, where he was a research fellow before joining the faculty of medicine at the University of Cape Town and Groote Schuur Hospital. Dr. Abrahamson was joint head of the endocrine unit in Cape Town before taking up a faculty appointment at Harvard Medical School and Beth Israel Hospital in 1992. Dr. Abrahamson’s research interests include evaluation of the efficacy and utility of a continuous glucose monitoring sensors in the management of patients with diabetes, and prevalence of silent coronary ischemia in patients with diabetes. Dr. Abrahamson is board certified in internal medicine and in endocrinology, diabetes and metabolism, and is a Fellow of the College of Physicians of South Africa.
  • Vivian A. Fonseca, MD, FRCP

    Vivian A. Fonseca, MD, FRCP

    Vivian A. Fonseca, MD, FRCP

    Professor of Medicine and Pharmacology; Chief, Section of Endocrinology

    Vivian A. Fonseca, MD, FRCP, is a professor of medicine and pharmacology, the Tullis-Tulane Alumni Chair in Diabetes, and chief, Section of Endocrinology, at Tulane University Health Sciences Center in New Orleans, Louisiana. His current research interests include the prevention and treatment of diabetic complications and risk factor reduction in cardiovascular disease. Dr Fonseca is a fellow of the American Association of Clinical Endocrinologists, the Royal College of Physicians (London) and the American College of Physicians, and is a member of the Endocrine Society, the American Diabetes Association, and the International Diabetes Federation. He serves on numerous national and international committees, and has published more than 200 papers, review articles and book chapters.
  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Richard Pratley, MD

    Richard Pratley, MD

    Richard Pratley, MD

    Samuel E. Crockett Chair in Diabetes Research; Director

    Richard E. Pratley, MD, is medical director of education and research at the Florida Hospital Diabetes Institute, senior investigator and diabetes program lead at the Translational Research Institute for Metabolism and Diabetes, and adjunct professor at the Sanford-Burnham Prebys Medical Discovery Institute in Orlando. His research interests include diabetes prevention, improving the care for older persons with diabetes, new drug development to treat and prevent diabetes and its complications, and understanding the role of the fat cell in increasing the risk of diabetes and heart disease. He is a member of numerous professional organizations, and is as an editorial board member and/or ad hoc reviewer for various journals. He received his MD from Wayne State University in Detroit, Michigan.
  • Anne L. Peters, MD

    Anne L. Peters, MD

    Anne L. Peters, MD

    Director, Clinical Diabetes Program; Professor, Keck School of Medicine

    Anne L. Peters, MD, is a professor of clinical medicine at the Keck School of Medicine of the University of Southern California in Los Angeles and the director of the USC Clinical Diabetes Program. Her interests involve translating research findings, from lifestyle interventions to technology, to people with diabetes throughout the socioeconomic spectrum. She is currently the chair of the Endocrine Society Committee on Diabetes Devices and is on the EASD/ADA Technology Safety Committee. Dr Peters has published over 200 articles, reviews and abstracts, and 3 books on diabetes, and has been an investigator on over 40 research studies. She earned her medical degree from the Pritzker School of Medicine at the University of Chicago in Illinois.
  • Jeremy H. Pettus, MD

    Jeremy H. Pettus, MD

    Jeremy H. Pettus, MD

    Assistant Professor of Medicine, Division of Endocrinology

    Jeremy H. Pettus, MD, is an assistant professor of medicine in the Division of Endocrinology at the University of California, San Diego (UCSD). After being diagnosed with type 1 diabetes himself at the age of 15, Dr Pettus has dedicated his career toward treating and educating others with the disease. He now specializes in type 1 diabetes-related clinical research with studies involving immunotherapeutics, islet cell encapsulation, and adjunctive therapies beyond insulin. He also has a background in basic immunology research with a focus on biomarkers for type 1 diabetes disease activity. In addition to his clinical duties, he is a speaker for the not-for-profit organization, Taking Control of Your Diabetes (TCOYD). He earned his medical degree from Boston University School of Medicine.
  • Andrew A. Moshfeghi, MD, MBA

    Andrew A. Moshfeghi, MD, MBA

    Andrew A. Moshfeghi, MD, MBA

    Associate Professor of Clinical Ophthalmology

    Andrew A. Moshfeghi, MD, MBA, is associate professor of clinical ophthalmology, as well as director of the Clinical Trials Unit and Retina Fellowship Program at the USC Roski Eye Institute, Keck School of Medicine, University of Southern California in Los Angeles. A noted vitreoretinal surgeon and recognized expert in diseases of the vitreous, retina and macula, his research concentrates on evaluation of intraocular pharmacotherapeutics, application of novel ophthalmic imaging techniques, and assessing health care utilization trends. Dr Moshfeghi earned his medical degree from Tulane University School of Medicine in New Orleans, Louisiana, and completed his medial retina and vitreoretinal surgery and diseases fellowship at the Bascom Palmer Eye Institute in Miami, Florida.
  • Timothy J. Murtha, MD

    Timothy J. Murtha, MD

    Timothy J. Murtha, MD

    Assistant Professor of Ophthalmology

    Timothy Murtha, MD, is a staff ophthalmologist at the Beetham Eye Institute of the Joslin Diabetes Center, and is an assistant professor in the Department of Ophthalmology at Harvard Medical School in Boston, Massachusetts. Dr Murtha’s clinical expertise extends into the arena of clinical research and trials, and his clinical interests include diabetic retinopathy, cataracts, and vitreoretinal disease. He has served as a clinical investigator for the Diabetes Control and Complications Trial and he has been active in the Diabetic Retinopathy Clinical Research Network (DRCR.net). Dr Murtha received his medical degree from the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School.
  • Wendy S. Lane, MD

    Wendy S. Lane, MD

    Wendy S. Lane, MD

    Director of Clinical Research

    Wendy S. Lane, MD, is a clinical endocrinologist and director of clinical research at the Mountain Diabetes and Endocrine Center in Asheville, North Carolina. Dr Lane has served as principal investigator or sub-investigator for multiple clinical trials for new and investigational oral and injectable medications and insulins for the treatment of type 1 and type 2 diabetes, as well as glucose sensor and insulin pump trials. She has been an author and investigator for several investigator-initiated trials of U-500 insulin via insulin pump and trials involving combinations of GLP-1 receptor agonist therapy with insulin. She was also a contributing author to 2014 AACE Guidelines on Insulin Pump Therapy. Dr Lane earned her medical degree at Dartmouth Medical School in Hanover, New Hampshire.